Epigenetic Silencing of Is an Early Event in Cancer and Is Associated with Luminal, Receptor Positive Breast Tumor Subtypes

Overview

Journal J Breast Cancer

Date 2017 Jul 11

PMID 28690657

Citations 11

Authors

Lukas Vrba

Bernard Walter Futscher

Affiliations

Soon will be listed here.

Abstract

Immortality is an essential characteristic of cancer cells; a recent transcriptomic study of epithelial cell immortalization has linked epigenetic silencing of the long noncoding RNA to this process. This study evaluated the epigenetic and transcriptional state of in two premalignant conditions-ductal carcinomas and colon adenomas. Results show that silencing is an early epigenetic event in human carcinogenesis, likely occurring near the point where premalignant cells gain immortality; this epigenetic silencing is maintained throughout malignant transformation and metastatic growth. Additional associations between MORT loss and clinical and molecular features of breast tumors showed that silencing of occurs predominantly in luminal, receptor-positive breast cancer; is associated with overexpression of and mutations of ; and is negatively correlated with mutations. Taken , silencing occurs early in breast carcinogenesis, probably during cellular immortalization, and precedes the development of invasive luminal breast cancer.

Citing Articles

Non-Coding RNAs in Breast Cancer: Diagnostic and Therapeutic Implications.

Benacka R, Szaboova D, Gulasova Z, Hertelyova Z Int J Mol Sci. 2025; 26(1.

PMID: 39795985 PMC: 11719911. DOI: 10.3390/ijms26010127.

Epigenetic Alterations in DCIS Progression: What Can lncRNAs Teach Us?.

Petrone I, Dos Santos E, Binato R, Abdelhay E Int J Mol Sci. 2023; 24(10).

PMID: 37240077 PMC: 10218364. DOI: 10.3390/ijms24108733.

Hypermethylation of Long Non-Coding RNA Genes Group in the Breast Cancer Development and Progression.

Filippova E, Selezneva A, Lukina S, Pronina I, Ivanova N, Kazubskaya T Bull Exp Biol Med. 2022; 173(6):765-769.

PMID: 36322308 DOI: 10.1007/s10517-022-05627-8.

LncRNA in Cancer-Is There a Possible Role in Gynecological Malignancies?.

Di Fiore R, Suleiman S, Drago-Ferrante R, Felix A, OToole S, OLeary J Int J Mol Sci. 2021; 22(15).

PMID: 34360598 PMC: 8346052. DOI: 10.3390/ijms22157829.

Analysis of Long Noncoding RNA ZNF667-AS1 as a Potential Biomarker for Diagnosis and Prognosis of Glioma Patients.

Yuan Q, Gao C, Lai X, Chen L, Lai T Dis Markers. 2020; 2020:8895968.

PMID: 33282010 PMC: 7685845. DOI: 10.1155/2020/8895968.

References

Knudsen E, Knudsen K . Tailoring to RB: tumour suppressor status and therapeutic response. Nat Rev Cancer. 2009; 8(9):714-24. PMC: 2914856. DOI: 10.1038/nrc2401. View

Johnson K, Koestler D, Fleischer T, Chen P, Jenson E, Marotti J . DNA methylation in ductal carcinoma in situ related with future development of invasive breast cancer. Clin Epigenetics. 2015; 7:75. PMC: 4514996. DOI: 10.1186/s13148-015-0094-0. View

Qu X, Sandmann T, Frierson Jr H, Fu L, Fuentes E, Walter K . Integrated genomic analysis of colorectal cancer progression reveals activation of EGFR through demethylation of the EREG promoter. Oncogene. 2016; 35(50):6403-6415. PMC: 5161754. DOI: 10.1038/onc.2016.170. View

Parker J, Mullins M, Cheang M, Leung S, Voduc D, Vickery T . Supervised risk predictor of breast cancer based on intrinsic subtypes. J Clin Oncol. 2009; 27(8):1160-7. PMC: 2667820. DOI: 10.1200/JCO.2008.18.1370. View

Vrba L, Garbe J, Stampfer M, Futscher B . A lincRNA connected to cell mortality and epigenetically-silenced in most common human cancers. Epigenetics. 2015; 10(11):1074-83. PMC: 4844203. DOI: 10.1080/15592294.2015.1106673. View

Garbe J, Vrba L, Sputova K, Fuchs L, Novak P, Brothman A . Immortalization of normal human mammary epithelial cells in two steps by direct targeting of senescence barriers does not require gross genomic alterations. Cell Cycle. 2014; 13(21):3423-35. PMC: 4613853. DOI: 10.4161/15384101.2014.954456. View

Umbricht C, Sherman M, Dome J, Carey L, Marks J, Kim N . Telomerase activity in ductal carcinoma in situ and invasive breast cancer. Oncogene. 1999; 18(22):3407-14. DOI: 10.1038/sj.onc.1202714. View

Yashima K, Milchgrub S, Gollahon L, Maitra A, Saboorian M, Shay J . Telomerase enzyme activity and RNA expression during the multistage pathogenesis of breast carcinoma. Clin Cancer Res. 1998; 4(1):229-34. View

Allred D, Mohsin S . Biological features of premalignant disease in the human breast. J Mammary Gland Biol Neoplasia. 2004; 5(4):351-64. DOI: 10.1023/a:1009573710675. View

10.

Reyngold M, Turcan S, Giri D, Kannan K, Walsh L, Viale A . Remodeling of the methylation landscape in breast cancer metastasis. PLoS One. 2014; 9(8):e103896. PMC: 4118917. DOI: 10.1371/journal.pone.0103896. View

11.

Abba M, Gong T, Lu Y, Lee J, Zhong Y, Lacunza E . A Molecular Portrait of High-Grade Ductal Carcinoma In Situ. Cancer Res. 2015; 75(18):3980-90. PMC: 4768486. DOI: 10.1158/0008-5472.CAN-15-0506. View

12.

Fleischer T, Frigessi A, Johnson K, Edvardsen H, Touleimat N, Klajic J . Genome-wide DNA methylation profiles in progression to in situ and invasive carcinoma of the breast with impact on gene transcription and prognosis. Genome Biol. 2014; 15(8):435. PMC: 4165906. DOI: 10.1186/PREACCEPT-2333349012841587. View

13.

. Comprehensive molecular portraits of human breast tumours. Nature. 2012; 490(7418):61-70. PMC: 3465532. DOI: 10.1038/nature11412. View

14.

Jenkins E, Deal A, Anders C, Prat A, Perou C, Carey L . Age-specific changes in intrinsic breast cancer subtypes: a focus on older women. Oncologist. 2014; 19(10):1076-83. PMC: 4200998. DOI: 10.1634/theoncologist.2014-0184. View

15.

Shpitz B, Zimlichman S, Zemer R, Bomstein Y, Zehavi T, LIVERANT S . Telomerase activity in ductal carcinoma in situ of the breast. Breast Cancer Res Treat. 2000; 58(1):65-9. DOI: 10.1023/a:1006394209922. View

16.

Luo Y, Wong C, Kaz A, Dzieciatkowski S, Carter K, Morris S . Differences in DNA methylation signatures reveal multiple pathways of progression from adenoma to colorectal cancer. Gastroenterology. 2014; 147(2):418-29.e8. PMC: 4107146. DOI: 10.1053/j.gastro.2014.04.039. View